L. E. Robertson

3.4k citations

41 papers · 2.8k indexed · h-index 25

Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 33
Hematology top 1%
- Acute Myeloid Leukemia Research 6
- Chronic Myeloid Leukemia Treatments 6
Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment 14
Immunology top 5%
- Immunodeficiency and Autoimmune Disorders 5
- T-cell and Retrovirus Studies 2
Oncology top 5%
Pulmonary and Respiratory Medicine
- Advanced Breast Cancer Therapies 7
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 7

Co-authors: Michael J. Keating Hagop M. Kantarjian Charles Koller William Plunkett Elihu H. Estey Susan Lerner Susan O’Brien Timothy J. McDonnell
Cited by: Genetics Hematology Pathology and Forensic Medicine
Journals: Blood (12 papers)Journal of Clinical Oncology (4 papers)Cancer Chemotherapy and Pharmacology (3 papers)
Partner nations: United States Netherlands Australia

In The Last Decade

L. E. Robertson

41 papers receiving 2.7k citations

Peers

Countries citing papers authored by L. E. Robertson

Since Specialization

Citations

This map shows the geographic impact of L. E. Robertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. E. Robertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. E. Robertson more than expected).

Fields of papers citing papers by L. E. Robertson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. E. Robertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. E. Robertson. The network helps show where L. E. Robertson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside L. E. Robertson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with L. E. Robertson Line = papers co-authored together L. E. Robertson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Fluorescence In Situ Hybridization Identifies Inversion 16 Masked by t(10;16)(q24;q22), t(7;16)(q21;q22), and t(2;16)(q37;q22) in Three Cases of AML-M4Eo Cancer Genetics and Cytogenetics ·Kavita S. Reddy,L. C. REARDON,Paul G. Montgomery,Burair Al Jassas,L. E. Robertson	2000	7
2	Prediction of Prognosis Following Fludarabine Used as Secondary Therapy for Chronic Lymphocytic Leukemia Leukemia & lymphoma ·Michael J. Keating,Terry L. Smith,Susan Lerner,Susan O’Brien,L. E. Robertson,Hagop M. Kantarjian,Emil J. Freireich	2000	29
3	Cellular pharmacodynamics and plasma pharmacokinetics of parenterally infused hydroxyurea during a phase I clinical trial in chronic myelogenous leukemia. Journal of Clinical Oncology ·Varsha Gandhi,William Plunkett,Hagop M. Kantarjian,Moshe Talpaz,L. E. Robertson,Susan O’Brien	1998	30
4	Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial Therapy Blood ·Michael J. Keating,Susan O’Brien,Susan Lerner,Charles Koller,Miloslav Beran,L. E. Robertson,Emil J. Freireich,Elihu H. Estey,Hagop M. Kantarjian	1998	345
5	Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabine Cancer Chemotherapy and Pharmacology ·L. E. Robertson,Y Chen,Yang O. Huh,William Plunkett,Michael J. Keating,J. Arly Nelson	1996	21
6	Results of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older The American Journal of Medicine ·Jörge E. Cortes,Hagop M. Kantarjian,Susan O’Brien,L. E. Robertson,Sherry Pierce,Moshe Talpaz	1996	28
7	Hodgkin's Disease Variant of Richter's Syndrome: Experience at a Single Institution Leukemia & lymphoma ·Vishwanath Thondamala,L. E. Robertson,Susan O’Brien,John T. Manning,Susan Wright,Frederick Hagemeister,Fernando Cabanillas,Michael J. Keating	1996	43
8	Survival of Young Patients with Chronic Lymphocytic Leukemia Failing Fludarabine Therapy: A Basis for the Use of Myeloablative Therapies Leukemia & lymphoma ·John F. Seymour,L. E. Robertson,Susan O’Brien,Susan Lerner,Michael J. Keating	1995	20
9	Implications of apoptotic cell death regulation in cancer therapy Seminars in Cancer Biology ·Timothy J. McDonnell,Raymond E. Meyn,L. E. Robertson	1995	62
10	Apoptosis in chronic lymphocytic leukemia L. E. Robertson,Peng Huang,Michael J. Keating,William Plunkett	1994	4
11	All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia Cancer ·Jörge E. Cortes,Hagop M. Kantarjian,Susan O’Brien,L. E. Robertson,Charles Koller,S. Rou-Jui Hu,Sanford A. Stass,Michael J. Keating,Elihu H. Estey	1994	36
12	Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor. Journal of Clinical Oncology ·Elihu H. Estey,Peter F. Thall,Michael Andreeff,Miloslav Beran,Hagop M. Kantarjian,Susan O’Brien,D. Byron May,L. E. Robertson,Charles Koller,Steven M. Kornblau	1994	243
13	Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacology Cancer Chemotherapy and Pharmacology ·Varsha Gandhi,L. E. Robertson,Michael J. Keating,W. Plunkett	1994	25
14	Original article: Fludarabine – present status and future developments in chronic lymphocytic leukemia and lymphoma Annals of Oncology ·Michael J. Keating,Peter McLaughlin,William Plunkett,L. E. Robertson,Susan O’Brien,Varsha Gandhi,V. Grégoire,Liying Yang,Fernando Cabanillas	1994	20
15	Richter's syndrome: a report on 39 patients. Journal of Clinical Oncology ·L. E. Robertson,William Pugh,S O'Brien,H Kantarjian,C Hirsch-Ginsberg,Ann Cork,Peter McLaughlin,Fernando Cabanillas,M Keating	1993	186
16	Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: Biology, clinical impact, and future directions Cancer treatment and research ·L. E. Robertson,Michael J. Keating	1993	6
17	Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment [see comments] Blood ·S O'Brien,Hagop M. Kantarjian,Miloslav Beran,Terry Smith,Charles Koller,Elihu H. Estey,L. E. Robertson,Susan Lerner,Michael J. Keating	1993	232
18	Apoptotic Cell Death in Chronic Lymphocytic Leukemia Leukemia & lymphoma ·L. E. Robertson,William Plunkett	1993	15
19	Hereditary factor VII deficiency in pregnancy: Peripartum treatment with factor VII concentrate American Journal of Hematology ·L. E. Robertson,Nathan Wasserstrum,Eugenio I. Bañez,Nguyen Nho Song Hoang,David Sears	1992	31
20	Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse. Journal of Clinical Oncology ·L. E. Robertson,J R Redman,James J. Butler,Barbara M. Osborne,William S. Velasquez,Peter McLaughlin,F Swan,Maria Alma Rodriguez,Fredrick B. Hagemeister,Lillian M. Fuller	1991	57

About L. E. Robertson

L. E. Robertson is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Immunology and Physiology, having authored 41 papers that have together received 2.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (14 papers), Advanced Breast Cancer Therapies (7 papers), Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and T-cell and Retrovirus Studies (2 papers). The work is most often cited by research in Genetics (1.8k citations), Hematology (849 citations), Pathology and Forensic Medicine (1.2k citations), Immunology (720 citations) and Oncology (596 citations). L. E. Robertson has collaborated with scholars based in United States, Netherlands and Australia. Frequent co-authors include Michael J. Keating, Hagop M. Kantarjian, Charles Koller, William Plunkett, Elihu H. Estey, Susan Lerner, Susan O’Brien, Timothy J. McDonnell, R. Ford and Sherri Chubb. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer and International Journal of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact